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Spheroids, which are near-spherical multicellular aggregates, are one of the most common types of three-dimensional (3D) cell cultures. In contrast to two-dimensional (2D) cell 
cultures, spheroids have the advantage of maintaining a diffusive 
nutrient and oxygen supply, leading to metabolic gradients from the 
periphery to the inner core and causing spatial heterogeneity in pro-
liferation, quiescence, necrosis and differentiation1,2. Spheroids are 
used as simplified biomimetic in vitro models to study fundamental 
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Spheroids are three-dimensional cellular models with widespread basic and translational application across academia and 
industry. However, methodological transparency and guidelines for spheroid research have not yet been established. The 
MISpheroID Consortium developed a crowdsourcing knowledgebase that assembles the experimental parameters of 3,058 
published spheroid-related experiments. Interrogation of this knowledgebase identified heterogeneity in the methodologi-
cal setup of spheroids. Empirical evaluation and interlaboratory validation of selected variations in spheroid methodology 
revealed diverse impacts on spheroid metrics. To facilitate interpretation, stimulate transparency and increase awareness, the 
Consortium defines the MISpheroID string, a minimum set of experimental parameters required to report spheroid research. 
Thus, MISpheroID combines a valuable resource and a tool for three-dimensional cellular models to mine experimental param-
eters and to improve reproducibility.
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mechanisms in biology and can be generated from a variety of cell 
cultures from healthy as well as pathological tissue, including can-
cer. Their scalability has promoted academic and industrial interest, 
particularly in the evaluation of drug responses or the biofabrica-
tion of 3D functional tissues or organs3–8. The scientific literature 
uses several alternative terms, such as spheres, tumor(o)spheres 
and mammospheres, with each having a different definition9. To 
avoid confusion, the general term ‘spheroid’ will be used, to cover 
all aforementioned terms.
Spheroid production is based on the principle of self-assembly, 
which occurs when cells present in a non-adherent environment 
aggregate together. To induce these cellular interactions, numerous 
spheroid formation methods have been established such as spin-
ner flasks, hanging drop cultures, microfluidic devices, cultures 
on low-adhesive substrates and so on3. Spheroid biology, including 
cellular interactions and cell death, severely affect drug responsive-
ness10,11. Specific changes in methodological setup, such as the nutri-
ent composition of cell culture media and the choice of spheroid 
formation method, may also contribute to differences in spheroid 
metrics12–16. Although there is no one-size-fits-all methodological 
setup for spheroid experiments, it is currently unclear how hetero-
geneity in methodology affects spheroid metrics. Consequently, the 
usage of a diverse set of experimental settings requires transparent 
reporting, without which results are difficult to interpret, compare 
and reproduce17,18.
Despite decades of implementation of spheroid technology 
in various fields of life science and medical research19,20, no mini-
mum information (MI) guidelines are available to cope with het-
erogeneity and encourage transparency. Minimum Information for 
Biological and Biomedical Investigations (MIBBI) provides access 
to the Minimum Information About a Cellular Assay (MIACA) 
and Minimum Information About Cell Migration Experiments 
(MIACME) guidelines, but these resources are not specific nor suf-
ficient for spheroid experimentation given that they do not cope 
with the complexity of a 3D experiment21–23. This situation is in 
contrast to that for other biological fields, in which minimum infor-
mation initiatives are available to define field-specific biological and 
technical parameters24–26.
To cope with this unmet need, we assembled an international 
consortium to develop the MISpheroID knowledgebase (https://
www.mispheroid.org). In-depth empirical evaluation and inter-
laboratory validation of selected variations in methodological 
setup identified a significant impact on a diverse set of spheroid 
metrics, while interrogation identified heterogeneity and a lack of 
transparency in published spheroid-related experiments. These 
results are merged into the generation of a minimum informa-
tion string for spheroid interpretation. Thus, MISpheroID is a 
unique open-access resource that facilitates systematic report-
ing on essential spheroid methodology with the aim to increase 
consistency and awareness in both academic and industrial 
research environments.
Results
Creation of the MISpheroID knowledgebase. An initial litera-
ture screening identified spheroids derived from breast cancer cells 
as the most reported in the past decade (Supplementary Table 1). 
Consequently, we first conducted an in-depth methodological anal-
ysis of 1,628 breast cancer spheroid-related experiments, of which 
1,506 were of human and 122 were of animal origin (Supplementary 
Fig. 1). For each experiment, we completed a checklist of 98 param-
eters relating to spheroid setup, characterization and application 
(Supplementary Table 2). Next, spheroid-related experiments 
from other tumor sites including the brain (n = 248), colorectum 
(n = 324), liver (n = 211), lung (n = 213), ovary (n = 243) and pan-
creas (n = 191) were evaluated, which resulted in an additional set 
of 1,430 experiments. Data were curated before inclusion in the 
MISpheroID knowledgebase, which to date includes a total of 3,058 
experiment entries.
Spheroid research practices. To identify practices in spheroid 
research, we performed an in-depth analysis of the MISpheroID 
knowledgebase. This found that 1,333 (of 1628, 81.9%) unique 
protocols have been reported to establish and characterize 
breast cancer spheroids (Supplementary Fig. 2). Visualization of 
MISpheroID data shows inconsistent reporting and/or heteroge-
neity in breast cancer spheroid setup, characterization and appli-
cation (Fig. 1). Culture medium type is not reported in 10% of 
experiments. In 47.5% of experiments the glucose concentration 
is not disclosed. This discrepancy probably results from the avail-
ability of 5.6 mM (low glucose, LG) and 25 mM (high glucose, HG) 
glucose-containing Dulbecco’s Modified Eagle’s Medium (DMEM) 
formulations and the ambiguous use of the term ‘DMEM’ to include 
all formulations of the medium. The spheroid formation method 
is efficiently reported (97.3%), with liquid overlay as the most fre-
quently applied method (71.1%, Supplementary Fig. 3). Of these 
experiments, 52% use ultra-low attachment (ULA) plates and 
42.1% use in situ coated plates. Agarose and poly-HEMA (46.9% 
and 28.8%, respectively) are the most implemented in situ coats. 
MISpheroID identifies 79 unique breast or mammary gland cell 
lines, with the estrogen-dependent MCF7 and T47D (542 (33.3%) 
and 96 (5.7%) out of 1,628 experiments, respectively) and the 
triple-negative MDAMB231 and 4T1 (337 (20.7%) and 63 (3.8%) 
out of 1,628 experiments, respectively) as the most frequently 
used breast or mammary gland cancer cell lines (Supplementary 
Fig. 4 and Supplementary Table 3). For each of these cell lines, a 
diverse set of culture media and formation methods is used to 
establish and study spheroids, although both variables are known 
to affect spheroid metrics11,12,14–16,27–30 (Extended Data Fig. 1 and 
Supplementary Fig. 5).
Although 87.8% of the breast cancer spheroid experiments are 
characterized by microscopy-based techniques, only 23.3% pro-
vide information about spheroid morphology. Despite the potential 
influence of spheroid size on study conclusions10,11, the numerical 
reporting of spheroid diameter (size), volume and projected area is 
described only in 21.0%, 4.5% and 2.9% of experiments, respectively. 
Shape assessment (for example, circularity) is performed in less than 
1% of experiments. Characterization by non-microscopy-based 
techniques is mainly focused on RNA (for example, quantita-
tive polymerase chain reaction, qPCR) and protein (for example, 
western blot) analysis in 26.6% and 25.9% of experiments, 
respectively (Fig. 1).
Spheroid application methods show that 23.9% of experiments 
focus on cancer stem cells, given that spheroid cultures from spe-
cific cell lines can be applied for cancer stem cell enrichment14. 
Functional assessments, such as migration and matrix invasion, 
are applied in 21.4% of experiments. Studies focused on patho-
physiology research and drug testing (48.3% and 24.6%) vastly 
outnumber those on spheroid 3D culture optimization (18.4%) 
(Supplementary Fig. 6).
In summary, breast or mammary gland cancer spheroid practices 
involve heterogeneity and/or lack of reporting in culture medium, 
spheroid formation method and spheroid size. Evaluation of these 
parameters for spheroid experiments from other tumor types indi-
cates that lack of reporting in culture medium and spheroid size 
is widespread in the spheroid research field (Fig. 2). Critically, 
detailed evaluation of the reported medium types and spheroid 
formation method for the most frequently used cell line from each 
tumor type reveals an extensive heterogeneity (Extended Data 
Fig. 2, Supplementary Figs. 7 and 8 and Supplementary Table 3).
Impact of methodological heterogeneity on spheroid met-
rics. The heterogeneity and reporting deficiencies exposed by 
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Fig. 1 | Mapping the reporting topography in breast cancer spheroid research. Binary heatmap showing the experimental parameters (rows, 51 of 98 
parameters, selected for relevance) of each spheroid experiment (columns, n = 1,628). The heatmap is divided vertically into three sections of parameters 
(‘setup’, ‘characterization both microscopic and non-microscopic’ and ‘application’; indicated in blue, light and dark green, and red; and including 18, 21 + 7, 
and 5 parameters, respectively) and horizontally according to the year of publication. For each section, rows are sorted in descending order according 
to total number of reported experimental parameters. Parameters that were not reported in an experiment appear as a white space in its corresponding 
column. The reporting efficiency of each parameter is indicated as a percentage in the right column. EM, electron microscopy; ECM, extracellular matrix.
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MISpheroID interrogation prompted us to empirically evaluate the 
impact of culture medium type, spheroid formation method and 
spheroid size on complementary spheroid metrics using established 
cell lines and early passage patient-derived cell cultures from differ-
ent tumor types.
Culture medium types commonly reported in the MISpheroID 
knowledgebase are DMEM (27.3%), DMEM/F12 (25.6%), 
RPMI1640 (18.1%), Minimum Essential Medium (MEM) (3.5%) 
and Eagle’s Minimum Essential Medium (EMEM) (0.6%), with each 
medium type having a different nutrient formulation (Extended 
Data Fig. 3). We measured media-induced transcriptional varia-
tion in lung cancer (A549), colorectal cancer (HCT116), ovarian 
cancer (SKOV3) and glioblastoma (U87MG) spheroids using RNA 
sequencing (RNA-seq). Principal component analysis showed dif-
ferential variation in transcriptional response to culture media, 
with A549 and SKOV3 having the largest variation (Fig. 3a). For 
A549 the media separated into two clusters (RPMI1640, EMEM and 
MEM versus DMEM/F12, DMEM LG and DMEM HG), while for 
U87MG the variation was less striking but was still apparent, with 
DMEM HG and DMEM LG in one cluster and the other medium 
types in a second cluster.
Gene set enrichment analysis (GSEA) using the 50 hallmark gene 
sets27 showed that the differentially expressed genes significantly 
converged on important hallmarks, and had medium-specific and 
cell type-specific patterns (Fig. 3b). In agreement with the princi-
pal component analyses, A549 and SKOV3 had the largest number 
of significantly enriched hallmark gene sets (37 and 38 of the 50 
analyzed, respectively). The hallmark gene set analysis revealed a 
unique distinction between medium types within each cell type. 
While some medium types in the A549 analysis (EMEM and 
MEM) and in the U87MG analysis (DMEM HG) showed an enrich-
ment of all hallmark signatures, other conditions showed discrete 
and unique diversities. The largest difference in the enrichment 
of hallmark gene sets between two medium types was observed 
for A549, DMEM/F12 versus MEM (mean difference, 1.90), for 
HCT116, DMEM/F12 versus MEM (mean difference, 1.08), for 
SKOV3, RPMI1640 versus MEM (mean difference, 1.09), and 
for U87MG, DMEM HG versus EMEM (mean difference, 2.45) 
(Supplementary Table 4).
To assess whether the medium-induced transcriptional changes 
are indicative of distinct cellular properties we examined spheroid 
metrics including cell death, adenosine triphosphate (ATP) con-
tent, ratio of lactate secretion to glucose uptake, secreted protein 
signatures of angiogenesis and immune interaction, circularity, 
size, and response to a cancer treatment intervention. These met-
rics were evaluated in the cell lines covered in the RNA-seq experi-
ments in addition to spheroids derived from tumor types such as 
liver (HEPG2), human breast (MCF7), pancreas (PANC1), mouse 
mammary gland (4T1) and sarcoma (early passage patient-derived 
cultures SAR030, SAR120 and SAR121). Metrics were visualized 
as a spider plot (as a transformed Z-score), allowing direct com-
parison of the contribution of each medium for each spheroid type 
(Fig. 4a). All spheroid metrics were affected by medium type in 
both established and early passage cell cultures. Medium-induced 
changes were shared by some of the cell cultures examined while 
others were cell type specific, underscoring how the heterogeneity 
of cancer15,16,31 can influence the cellular responses to environmen-
tal conditions. For example, a consistent increase in cell death was 
observed in 9 of 11 cell types for RPMI1640, whereas an increase in 
cell death was observed only in 3 of 11 cell types in the lower nutri-
ent media DMEM LG, EMEM and MEM (Extended Data Fig. 4). In 
some conditions, cell death occurred particularly in the spheroid 
center, suggesting necrotic core formation (Extended Data Fig. 5).
Cellular ATP content, as a measure of metabolic activity, was 
lowest in the nutrient-poor medium EMEM in 8 of 11 cell types 
(Extended Data Fig. 6). Although commonly related to nutrient 
deprivation, the cause of necrotic core formation in the multicel-
lular tumor spheroids is still controversial32. Nutrient-poor condi-
tions correlated with increased cell death and low ATP content in 
some cell types (HCT116 and 4T1) but not in all. A549 spheroids 
cultured in the nutrient-poor media EMEM and MEM had low ATP 
content but decreased cell death. We measured glucose consump-
tion and lactate secretion in supernatants of spheroids from five cell 
lines. This L/G ratio was profoundly influenced by medium type in 
all cell types, with the lowest ratio in the high glucose-containing 
media DMEM/F12 and DMEM HG (Extended Data Fig. 7). In 
contrast, two independent studies using 2D cultured cell lines 
(including A549) did not observe changes in the conversion of 
glucose to lactate when cultured in different media13,16, suggesting 
the importance of 3D culture-induced nutrient gradients in these 
metabolic changes.
Furthermore, culture medium strongly influenced the secre-
tion of proteins implicated in angiogenesis and immune cell 
interaction (Supplementary Table 5), which are crucial for tumor 
micro-environment (TME) communication. For example, the 
angiogenic and immune interactive potential of 4T1 scored high 
in DMEM LG, but low in DMEM/F12. In contrast, A549 scored a 
high TME interactivity in DMEM/F12 but a low TME interactiv-
ity in DMEM LG (Supplementary Fig. 9). Spheroid morphology, in 
terms of circularity, ranged between a circularity index of 0.75 and 
0.95 in all tested cell lines and differed significantly between cell 
types (for example, the circularity index of MCF7 was 0.79 ± 0.08 
and that of HCT116 was 0.94 ± 0.02). Intriguingly, spheroids cul-
tured in RPMI1640 had the lowest circularity in 7 of 11 cell types 
(Extended Data Fig. 5 and Supplementary Fig. 10). The metric 
spheroid size varied significantly with medium type in 10 of 11 cell 
types analyzed (Extended Data Fig. 8 and Supplementary Table 6). 
Except for HCT116, MCF7 and SAR121, the nutrient-poor media 
EMEM or MEM had the smallest spheroids in all cell types analyzed 
(Extended Data Fig. 5). Size correlated significantly with cellular 
ATP content (median Pearson’s r = 0.53, two-tailed P < 0.0001).
All these medium-induced changes in spheroid metrics war-
ranted investigations into the response to a treatment intervention. 
Radiotherapy is used in >50% of patients with tumors in sites such 
















Brain Breast Colorectum Liver Lung Ovary Pancreas
Fig. 2 | Reporting efficiency of experimental parameters in spheroids from 
different tumor types. Spider plot visualization of the reporting percentage 
of cell line, culture medium, formation method and size in spheroids from 
different tumor types (clockwise). Axes represent the percentage of 
reporting efficiency.
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Fig. 3 | Culture media-induced transcriptional variation. a, Principal component analysis of gene expression profiles from spheroids of four cancer cell 
lines cultured in six different medium types. b, Heatmap of Z-scores of all MSigDB hallmark gene sets identified by GSEA to be significantly enriched 
among the differentially expressed genes across the culture medium types in each cell line. Medium types are ranked from higher nutrient (left) to lower 
nutrient (right) richness.






















































































































































































































































Fig. 4 | Culture media-induced heterogeneity in spheroid metrics across multiple cell types. a, Spider plots of metrics from spheroids of indicated cell 
lines cultured in six different medium types. Axes represent the Z-score metrics of cell death, ATP content, L/G ratio, secreted protein signatures of 
angiogenesis and immune interaction, circularity, size and therapy response. A higher Z-score means a higher metric value. The left and middle columns 
indicate established cell lines; early passage and patient-derived sarcoma cultures are on the right. b, Cell death of HCT116 spheroids cultured in six 
different medium types evaluated at seven different laboratories (“sites”) in an interlaboratory experiment. At each site a higher ranking indicates a higher 
cell death. Each dot represents an evaluated spheroid. The colors indicate the medium type as in a.
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common models to evaluate radiotherapy response1. In our evalu-
ated cell lines, the medium type significantly influenced the radio-
therapy response. Specifically, 4 of 5 investigated cell lines had the 
largest response to a 20 Gy fraction in DMEM LG culture medium 
(Extended Data Fig. 9a,b). The medium-dependent variability in 
radiotherapy response could not be explained by irreproducibility 
of the assay. First, biological replicate treatments yielded highly con-
cordant results (median Pearson’s r = 0.90, two-tailed P < 0.0001). 
Second, a 10 Gy fraction had similar patterns of activity across cell 
lines (Extended Data Fig. 9c,d).
To validate our results, we initiated an interlaboratory study to 
chart cell death, circularity and size in HCT116 spheroids cultured 
in six different media (Fig. 4b). The study used short tandem repeat 
(STR)-confirmed HCT116 cells, available at each participating lab-
oratory, to allow for a realistic situation in which diversity occurred 
not only as a result of heterogeneity in culture media but also 
through differences in passage number, serum batches, pre-spheroid 
and laboratory-specific culture conditions, researchers and instru-
ments. A dot plot analysis of the ranking of cell death in each ana-
lyzed spheroid (Fig. 4b) reproduced a specific pattern of media 
impact across different sites with a median Spearman correlation 
across the entire dataset of 0.91. The median correlation between 
biological replicates at the study-initiating laboratory (site 1) was 
only slightly higher, at 0.96 (Extended Data Fig. 10a). Furthermore, 
in agreement with results generated in the study-initiating labora-
tory, RPMI1640 was validated as the medium in which spheroids 
had the lowest circularity (in 4 of 6 external sites), and DMEM LG 
was validated as the medium in which spheroids had the largest size 
(in 5 of 6 external sites) (Extended Data Fig. 10b,c). Consequently, 
the interlaboratory data on HCT116 spheroids were indicative of 
the robustness of the impact of medium heterogeneity on spheroid 
metrics and demonstrated the generalizability of our findings.
An impact of spheroid formation methods on morphology-related 
spheroid metrics has been shown clearly in previous reports28–30,34. 
The two most frequently reported formation methods (hang-
ing drop and liquid overlay using ULA plates) in A549, HCT116, 
SKOV3 and 4T1 cell cultures (Supplementary Figs. 5 and 8) were 
compared in one medium type (DMEM LG), and this showed that 
ATP content, circularity and size were profoundly affected by for-
mation methodology in a cell type-specific manner (Fig. 5a and 
Supplementary Fig. 11).
Spheroid size, a parameter influencing hypoxia and necrotic core 
formation1, is largely underreported in MISpheroID. Spheroids with 
different seeding cell numbers at the start of the experiment had 
size-dependent changes in the metrics cell death and ATP content 
(Fig. 5b, Supplementary Figs. 12 and 13 and Supplementary Table 
6), which confirmed previous reports of the importance of spher-
oid size on spheroid characteristics10,11. Differences were observed 
in most culture media for all cell types evaluated. Intriguingly, the 
smallest (<550 µm) HCT116 spheroids showed medium-dependent 
changes in ATP but not in cell death. Thus, depending on cell line, 
spheroid size differentially affected spheroid metrics within a cer-
tain medium type but also between medium types.
The spheroid community is challenged by heterogeneity and 
reporting deficiencies that cause a significant variation in the 
readout of one or more spheroid metrics in a cell type-specific manner. 
Our analyses underscore the importance of transparent reporting of 
experimental parameters affecting spheroid interpretation.
Creation of the MISpheroID tool. Transparency expectations to 
ensure experimental robustness and reproducibility have prompted 
the creation of reporting tools in various fields17,18,21–26. In accor-
dance with MISpheroID knowledgebase interrogation, in-depth 
empirical evaluation and available supportive literature10–13,28–30,34, 
the MISpheroID Consortium recommends the introduction of 
the MISpheroID tool in the spheroid community. This tool gener-
ates a spheroid ID string consisting of four components that the 
Consortium argues to be the minimum information required for 
interpretation, comparison and replication of spheroid experi-
ments: cell type(s) (one or multiple cell types (co-culture) included 
in one spheroid), culture medium (the environment in which spher-
oids are formed and cultivated), spheroid formation method (that 
is, liquid overlay (for example, ULA plates), hanging drop, spinner 
flask, microfluids and so on), and size (the diameter ± s.d. of the 
spheroid after spheroid formation (at the moment of application)).
Typical example of an MISpheroID string. A representative 
example of an MISpheroID string is [4T1 – EMEM – Liquid 
overlay – 348 ± 23 µm].
Currently, only 300 of 1,628 (18.4%) breast cancer-related spher-
oid experiments provide all four components of the MISpheroID 
string. Global reporting of MISpheroID string parameters shows 
that some are reported relatively more often (that is, cell line and 
spheroid formation method) than others (that is, culture medium 
and size). Importantly, in 80.7% of the experiments, an increase in 
MISpheroID string reporting can be achieved without additional 
experiments (correct reporting of medium type and size, based on 
available microscopy images).
Using the MISpheroID platform. We invite the community to 
upload spheroid experiments through https://www.mispheroid.
org (Fig. 6). As part of each upload, 31–55 (depending on 
sub-questions) experimental parameters related to cell type, culture 
medium, spheroid formation method and size are recorded and are 
fully compatible with queries for deeper information. Each anno-
tated experiment receives a MISpheroID string and unique registra-
tion code. The MISpheroID string does not reflect the quality of a 
spheroid experiment, nor does it impose a specific methodology, 
but it improves spheroid research transparency and experimental 
design. Users can search the knowledgebase for articles using a 
range of search parameters. The query result list is accompanied by 
a MISpheroID string and Pubmed ID (PMID). MISpheroID query-
ing stimulates awareness and motivates researchers to compare gen-
eral and specific information. We encourage researchers to provide 
feedback about the knowledgebase and transparency tool using the 
contact section of MISpheroID (Fig. 6).
Discussion
Spheroids are attractive 3D tissue structures for research purposes, and 
rapid progress in imaging, automated high-throughput production 
Fig. 5 | Effect of formation methodology and spheroid size-induced heterogeneity on spheroid metrics across multiple cell types. a, Spider plot of 
metrics from spheroids of indicated cell lines generated by the hanging drop (red) or liquid overlay (green) spheroid formation method. Axes represent 
the Z-score metrics of cell death, ATP content, secreted protein signatures of angiogenesis and immune interaction, circularity and size. A higher Z-score 
means a higher metric value. b, Violin plots representing the impact of spheroid size on cell death (upper panel) and ATP content (lower panel) metrics of 
HCT116 spheroids cultured in six different media. Each biological replicate has a different symbol (N ≥ 3), and each symbol is a technical replicate (n = 8). 
Triangles at the X axis represent increasing seeding cell number and consequently increasing spheroid size; for absolute size estimates see Supplementary 
Table 6. The Y axis represents log2-transformed data, and all media are normalized to DMEM HG. The horizontal bar indicates the median. Statistical 
significance between the groups was determined with a one-way ANOVA and Tukey’s multiple comparison test. **P < 0.01, ***P < 0.001, ****P < 0.0001. 
Colors indicate medium type; media are ranked from higher nutrient (left) to lower nutrient (right) richness.
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and microfluidic technologies ensures their future implementa-
tion in drug screening, tumor biology studies and tissue engineer-
ing. However, to reach its full potential, there must be in-depth 
reporting of the diverse experimental parameters in the method-
ological setup of spheroids. This study objectively demonstrates that 
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and spheroid size significantly affect the phenotypic landscape of 
spheroids. Although it was not the Consortium’s aim to identify the 
causes of the culture medium-induced changes in spheroid metrics, 
we expect that the non-physiological concentrations of some nutri-
ents affect 3D biology in a cell context-dependent manner. The choice 
of medium type should be considered when designing studies that 
aim to explore pathophysiology or that aim to identify the depen-
dency of cancer cells on specific signaling pathways, or when inves-
tigating the effects of therapeutic intervention (such as radiotherapy 
in this study). Most importantly, failure to understand heterogeneity 
can result in data that are difficult to interpret and reproduce.
The MISpheroID tool reflects the process of generating a spher-
oid to allow evaluation of experimental consistency and straight-
forward resource exchange for understanding spheroid data output 
(biology, drug screening and so on). Some of the challenges (cell 
line and culture medium) are not unique to the spheroid field and 
have been discussed previously21–23. We recognize that achieving 
a meaningful improvement in the transparency of reporting will 
require engagement and acceptance from all stakeholders, including 
investigators, reviewers, funding agencies and journal editors17,18,25.
The MISpheroID resource has its limitations, which should be 
considered. First, empirical data are obtained from monoculture 
spheroids; co-cultures were not analyzed in this study. Second, 
spheroid metrics were evaluated at a fixed predefined time point; 
longitudinal analyses were not included in the study. Third, the 
knowledgebase covers a high number of spheroid experiments 
representing cancer biology but does not cover spheroid experi-
ments from other fields, thereby potentially underestimating the 
full spheroid landscape. Despite these limitations, the knowledge-
base contains information on non-cancer cells present in spheroid 
co-culture experiments such as mesenchymal and immune cells. 
Considering differences in metabolic demands for non-cancer cells, 
the components of the MISpheroID knowledgebase and tool are 
equally useful for non-cancer cells. Other emerging 3D model sys-
tems, such as organoids and self-renewing multicellular aggregates 
that self-organize into lumen-containing ex-vivo organs, may also 
benefit from the MISpheroID tool to improve transparency and 
document heterogeneity35.
We developed MISpheroID to capture and disseminate 
data related to spheroid models and we will continue to evolve 
MISpheroID to reflect the state of the art in the field. Given the 
recent success of immune checkpoint inhibitors in the treatment 
of cancer, improving the immune component of spheroid models 
can be steered with knowledge accumulated in this study such as 
protein secretion in spheroid supernatants (for specific secretion 
profiles see the source data files). Recent advancements in technol-
ogy will facilitate more in-depth characterization and reporting of 
spheroid metrics. For example, breakthroughs in submillimeter par-
ticle characterization in geology, engineering and the food indus-
try may lead to better 3D characterization of spheroid sphericity 
and compaction36.
As has been demonstrated across multiple domains, adoption 
of minimum information by a research community accelerates 
the rate of transparency and drives scientific progress. Reporting 
of the minimum information required is already compulsory or 
recommended for publishing in several journals24. MISpheroID 
contributes to the field of 3D spheroid biology by providing first, 
a knowledgebase that catalogs spheroid setup, characterization and 
applications to enable the community to share and access key tech-
nical and biological insights in 3D experimentation; second, mini-
mum information parameters combined with a tool to implement 
them; and last, a resource containing experimental data demon-
strating the impact of experimental variations on spheroid metrics. 
In conclusion, the MISpheroID Consortium aims to advance 3D 
biology in both academic and industrial environments by removing 
the barriers of inconsistency while promoting reproducibility.
Online content
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Fig. 6 | Implementation of the MISpheroID knowledgebase. This flowchart illustrates the application of MISpheroID.
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Methods
Literature search. Medline (PubMed) was searched for articles applying active 
spheroid formation methods with cancer cells (cell lines and early passage 
patient-derived cell cultures). Therefore, the following key terms were applied: 
spheroid (and derived terms), cancer, neoplasm, tumor and ‘organ’ (brain, breast, 
colorectum, liver, lung, ovary and pancreas). We focused on active spheroid 
formation, therefore at abstract check, reviews and letters were excluded as well as 
articles that did not involve active spheroid formation or those in which spheroids 
did not include organ-specific cells. At full-text screening, we applied the same 
exclusion criteria and excluded articles for which the full text was not available. 
Spheroids from multiple cell lines or spheroid formation methods were considered 
as a separate experiment. For the breast cancer spheroid-related articles used to set 
up the knowledgebase, published articles from 1979 to 2020 were evaluated. For 
the spheroid-related articles from other organ tumor types, published articles from 
2018 to 2021 were evaluated. As an example, a detailed flow chart for literature 
screening of breast of breast cancer spheroids is provided in Supplementary Fig. 1.
Experimental setup. An overview schematic (Supplementary Fig. 14) explains 
the use of different cell types, methodological setups and metrics evaluated in the 
study as detailed in the Methods section.
Cell culture. The cell lines A549 (cat. no. CCL-185), HCT116 (cat no. CCL-247), 
HEPG2 (cat. no. HB-8065), MCF7 (cat. no. HTB-22), PANC1 (cat. no. CRL-1469), 
SKOV3 (cat. no. HTB-77), U87MG (cat. no. HTB-14) and 4T1 (cat. no. CRL-2539) 
were purchased from the American Type Culture Collection. To establish the early 
passage cell cultures (SAR030, SAR120 and SAR121), patient-derived sarcoma 
samples (Supplementary Table 7) were cut into pieces measuring 1–2 mm3. The 
pieces were digested in 500 U ml−1 collagenase II solution (cat. no. 17101015, 
ThermoFisher) and 22 KU ml−1 DNase I solution (cat. no. A3778.0010, VWR) 
and processed according to the Gentlemax tumor digestion protocol (Miltenyi 
Biotec). The cell suspension was applied to a cell strainer (100 μm, cat. no. 352360, 
Corning), centrifuged at 300×g for 5 min and, after aspiration of the supernatant 
and removal of remnant red blood cells, maintained in culture. All human cell 
lines were authenticated using a 21-Marker STR Profile test (Eurofins) and tested 
monthly using the Mycoalert Mycoplasma Detection Kit (cat. no. LT07-318, Lonza) 
to exclude mycoplasma contamination. All cells were cultured in DMEM (cat. no. 
41965039, ThermoFisher) supplemented with 10% heat-inactivated fetal bovine 
serum (FBS) (cat. no. ATCC-30-2030, LGC Standards), 100 IU ml−1 penicillin and 
100 mg ml−1 streptomycin (cat. no. 15070063, ThermoFisher). Cells were expanded 
and maintained as a monolayer at 37 °C in an atmosphere of 5% CO2 in air and 
passaged at 80% confluence.
Spheroid formation. The U-shaped, 384-well ULA plates (cat. no. MS-9384UZ, 
S-bio) were seeded with a suspension of 80 µl cell culture media with 2 × 10³ 
cells per well (A549, HCT116, HEPG2, MCF7, PANC1, SKOV3, U87MG, 4T1, 
SAR120, SAR121) or 8 × 10³ cells per well (SAR030) in 2 × 8 technical replicates 
per condition. The culture media used were DMEM HG (4.5 g l−1 = 25 mM glucose) 
(cat. no. 41965039, ThermoFisher), DMEM/F12 (1:1) (3.15 g l−1 = 17.5 mM glucose) 
(cat. nos. 41965039 and 21765029, ThermoFisher), RPMI1640 (2 g l−1 = 11.1 mM 
glucose) (cat. no. 21875091, ThermoFisher), DMEM LG (1 g l−1 = 5.6 mM glucose) 
(cat. no. 31885023, ThermoFisher), EMEM (1 g l−1 = 5.6 mM glucose) (cat. no. 
10-009-CV, Corning) and MEM (1 g l−1 = 5.6 mM glucose) (cat. no. 10370-047, 
ThermoFisher), all supplemented with 10% FBS, 100 IU ml−1 penicillin and 
100 mg ml−1 streptomycin. Note that 5.6 mM glucose is the physiological plasma 
glucose concentration. MEM was supplemented with 2 mM l-glutamine. Extended 
Data Fig. 3 provides extensive details on the nutrient content of 10 culture media 
reported in MISpheroID, of which six were empirically evaluated. The 384-well 
ULA plates were sealed with Breathe-Easy semipermeable tape (cat. no. BEM-1, 
Diversified Biotech) to prevent evaporation. The spheroids were cultured at 37 °C 
in an atmosphere of 5% CO2 under normoxia.
For the comparison of spheroid size, 2 × 103, 4 × 103, 6 × 103 or 8 × 103 cells 
(A549 and SKOV3) and 0.5 × 103, 1 × 103, 2 × 103 or 3 × 103 cells (HCT116) were 
seeded in 80 µl cell culture media in the U-shaped, 384-well ULA plates. The 
culture media used were DMEM HG, DMEM/F12, RPMI1640, DMEM LG, EMEM 
and MEM.
For the comparison of the liquid overlay method and the hanging drop 
method, 2 × 103 cells (A549, HCT116, SKOV3, 4T1) were seeded in 80 µl 
cell DMEM LG in U-shaped 96-well ULA plates (cat. no. CLS7007-24EA, 
Sigma-Aldrich) in the liquid overlay method. In the hanging drop method, 2 × 103 
cells were plated under the lids of petri dishes (cat. no. A19618, Novolab) in 20 µl 
drops of DMEM LG (50 technical replicates). The bottom of the petri dishes was 
filled with 10 ml PBS (phosphate buffered saline; cat. no. 20012019, ThermoFisher) 
to limit evaporation.
RNA sequencing. Spheroids from four independent cell lines using four technical 
replicates from one biological replicate were used and cultured in 384-well 
ULA plates in six different cell culture media (a total of 96 conditions) for 5 d 
(HCT116) or 7 d (A549, SKOV3 and U87MG). RNA extraction was performed 
on two spheroids per condition using the miRNeasy Micro Kit (cat. no. 217084, 
Qiagen). RNA-seq libraries were prepared from purified RNA using the QuantSeq 
3’ mRNA-Seq Library Prep Kit FWD for Illumina (Lexogen) according to the 
manufacturer’s instructions, with 27.5 ng RNA that was treated with Heat-Labile 
Double Strand-specific DNase (Arcticzymes). The individual libraries were 
quantified by qPCR using the KAPA Library Quantification Kit (Roche) and 
equimolarly pooled. The pool concentration was measured with Qubit, and 
sequencing was carried out at a concentration of 1.4 pM with 1% PhiX on a 
NextSeq 500 (Illumina) (NextSeq software v.4.0.1) using a high-output 1 × 75 
run. Reads were mapped to the human genome using Tophat and gene expression 
counts were generated using HTSeq.
Data normalization and gene set enrichment analysis. Normalization and 
differential gene expression analysis were performed using DESeq2 (v1.30.1). 
Terms from the Molecular Signatures Database (MSigDB) Hallmark Gene 
Signatures27 were used for enrichment analysis with GSEA software (v4.1.0). We 
tested gene sets for significant enrichment among the differentially expressed 
genes between the six medium types used to culture the spheroids in each cell 
line, to assess how they might differ from each other in terms of molecular 
pathways. Statistical significance between the different media for all hallmarks was 
determined for every cell line using one-way analysis of variance (ANOVA) and 
Tukey’s multiple comparison test with the alpha level of significance set at 0.05. 
Principal component analysis with the Manhattan distance index was performed 
using PAST4.03.
Cell death staining. Spheroids were cultured in the 384-well ULA plates in the 
different cell culture media for 5 d (HCT116) or 7 d (all other cell lines). For 
the comparison of the liquid overlay method and the hanging drop method, 
spheroids were cultured for 3 d. A total of 60 µl medium per well was replaced 
with 10 µM Ethidium homodimer I solution (cat. no. 300519, Santa Cruz) in PBS 
supplemented with Ca2+ and Mg2+. The hanging drop spheroids were transferred 
to the 96-well ULA plate and 60 µl 10 µM Ethidium homodimer I solution was 
added. The fluorescence signal was observed after 15 min incubation time at 20 °C 
room temperature with an Axiovert 200 M fluorescence microscope (Carl Zeiss) 
using AxioVision release 4.8. The average dead signal was measured over the 
spheroid area in ImageJ (v1.52v.). Analysis was performed on a minimum of three 
biological replicates, with each biological replicate having eight technical replicates 
per condition. Statistical significance between the groups was determined with 
a one-way ANOVA and Tukey’s multiple comparison test with the alpha level of 
significance set at 0.05.
Interlaboratory study. The study-initiating laboratory sent culture media, 384-well 
ULA plates and Breathe-Easy semipermeable tape to six different laboratories 
that were part of the international MISpheroID Consortium. To perform the 
experiments, the laboratories added their own batches of serum to the culture 
media. All cells were authenticated by STR profiling. To conduct the dead staining, 
laboratories applied in-house optimized dead staining protocols, after which the 
raw data concerning dead signal, spheroid circularity and size were analyzed by the 
study-initiating laboratory.
ATP assay with CellTiter-Glo 3D. Spheroids were cultured in 384-well ULA plates 
in the different cell culture media for 5 d (HCT116) or 7 d (all other cell lines). 
For the comparison of the liquid overlay method and the hanging drop method, 
spheroids were cultured for 3 d. Individual spheroids in the culture medium were 
pipetted into white micro 96-well plates (cat. no. 236108, ThermoFisher) and an 
equal volume of CellTiter-Glo 3D (cat. no. G9683, Promega) reagent was added. 
The contents were mixed for 5 min on an orbital shaker to induce cell lysis, while 
shielded from light. Luminescence readout (Gen5 Data Analysis Software v3.08.01) 
was performed after 25 min incubation at 20 °C (room temperature). Analysis 
was performed on a minimum of three biological replicates, with each biological 
replicate having eight technical replicates per condition. Statistical significance 
between the groups was determined with a one-way ANOVA and Tukey’s multiple 
comparison test with significance level alpha 0.05.
Irradiation. Spheroids were cultured in the 384-well ULA plates in the different 
cell culture media for 3 d before being irradiated with 10 or 20 Gy single fractions 
with 6 MV photons from an Elekta Synergy linear accelerator (Elekta). Irradiation 
response was measured and calculated after 2 d (HCT116) or 4 d (SKOV3, U87MG 
and 4T1) with the percentage change in metabolic activity (CellTiter-Glo 3D) 
compared with non-irradiated control spheroids. Analysis was performed on 
a minimum of eight technical replicates per condition. Statistical significance 
between the groups was determined with a one-way ANOVA and Tukey’s multiple 
comparison test with the alpha level of significance set at 0.05.
Measurement of glucose and lactate. Endpoint concentrations of glucose 
and lactate in the spheroid supernatants were measured using enzymatic 
assays involving bioluminescent NADH detection technology and a selective 
dehydrogenase (Glucose-Glo J6021 and Lactate-Glo J5021 assay; Promega). For 
the glucose-Glo assay, supernatants of spheroids cultured in DMEM HG and 
DMEM/F12 were diluted 1:500 in PBS, and supernatants of spheroids cultured 
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in RPMI1640, DMEM LG, EMEM and MEM were diluted 1:200 in PBS. For the 
lactate-Glo assay, supernatants of spheroids were diluted 1:100 in PBS. Controls 
(medium without cells) were diluted correspondingly. A 50 µl sample was pipetted 
into white micro 96-well plates (cat. no. 236108, ThermoFisher) and an equal 
volume of assay reagent was added. The contents were mixed for 30 s on an orbital 
shaker while shielded from light. Luminescence readout (Gen5 Data Analysis 
Software v3.08.01) was performed after 1 h incubation at room temperature. 
Glucose consumption and lactate production were calculated by subtraction of 
the glucose or lactate concentrations of the medium without cells. Analysis was 
performed on a minimum of two biological replicates with each biological replicate 
having four technical replicates per condition. Statistical significance between the 
groups was determined with a Kruskal–Wallis test with Dunn’s correction, with the 
alpha level of significance set at 0.05.
Luminex. Spheroids were cultured in the 384-well ULA plates in the different cell 
culture media for 5 d (HCT116) or 7 d (all other cell lines). For the comparison of 
the liquid overlay method and the hanging drop method, spheroids were cultured 
for 3 d. Eight technical replicates (liquid overlay method) or 42 technical replicates 
(hanging drop method) were then collected and the supernatant was passed 
through a 0.2 µm filter (cat. no. A37111, Novolab) and processed with the Human 
Cytokine/Chemokine Array 71-Plex Panel and the Human Angiogenesis Array 
and Growth Factor 17-Plex Array by Eve Technologies. The supernatant collected 
from the 4T1 mouse mammary gland cell line was processed with the Mouse 
Cytokine/Chemokine Array 44-Plex Panel. Analysis was performed on a minimum 
of three biological replicates per condition with subtraction of the growth factor 
concentrations of medium without cells. Growth factors were grouped based on 
their GO-Biological processes related to immune interaction or angiogenesis via 
the UniProt Knowledgebase.
Size and circularity calculations. Spheroid size (diameter) and circularity 
were determined using AnaSP v1.4 (ref. 37). The spheroid size was described by 
the equivalent diameter (ED). The ED is the diameter of a circle with the same 
projected area as the spheroid, calculated by
ED = 2√ (area/π) (1)
The spheroid circularity was determined by the formula:
circularity = 4π × area/ (convex perimeter)2 (2)
Z-score calculations. Z-scores were calculated in Excel (v.2106) according to the 
formula
Z = (x − μ) /σ
with x being the value of every replicate, µ being the average of the population 
(all replicates over the different media), and σ being the standard deviation of the 
population (all replicates over the different media).
The Z-score of a culture medium was subsequently calculated as the average of 
the Z-scores for that culture medium.
Outlier exclusion. Data points were first excluded manually (for example, 
spheroids containing a dust particle when measuring dead signal, spheroids that 
were lost when pipetting to a white plate for measuring metabolic activity with 
CellTiter-Glo 3D and so on). Afterwards, outliers were calculated via the ROUT 
method (Q = 1%) with Graphpad Prism v8.4.3, taking into account that the 
number of datapoints plotted in the graphs can be lower than N × n due to outlier 
exclusion.
Statistical analysis. Statistical analysis was performed in Graphpad Prism v8.4.3. 
Unpaired comparisons were conducted using a one-way ANOVA or Kruskal–
Wallis test (after the mentioned transformations and the Shapiro–Wilk assessment 
for normality) with Tukey’s or Dunn’s multiple comparison test. Comparisons of 
the spheroid formation method were conducted using unpaired Student’s t-test 
with Welch’s correction. Correlation analysis was conducted by determination of 
Pearson or non-parametric Spearman correlation coefficients. The significance 
level for all tests was 0.05, however, in the Figures the statistical significance is 
shown only for significance levels ≤ 0.01.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
RNA-seq data generated during the current study are available in the ArrayExpress 
database (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-10862.
The source data underlying Figs. 1–5, Extended Data Figs. 4–10, Supplementary 
Figs. 9–13 and Supplementary Table 6 are provided as a source data file. All 
literature study data are available through the MISpheroID knowledgebase. Source 
data are provided with this paper.
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Extended Data Fig. 1 | Distribution of the applied culture medium to prepare spheroids of the estrogen-dependent MCF7 and T47D, and triple-negative 
MDAMB231 and 4T1 breast/mammary gland cancer cell lines. Pie chart visualizing the proportion of culture media used to prepare MCF7, T47D, 
MDAMB231 and 4T1 spheroids.
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Extended Data Fig. 2 | Distribution of the applied culture medium to prepare spheroids of the most reported cell line from non-breast tumors. Pie chart 
visualizing the proportion of culture media used to prepare A549 (lung), HCT116 (colorectal), HEPG2 (liver), PANC1 (pancreas), SKOV3 (ovarium) and 
U87MG (brain).
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Extended Data Fig. 3 | See next page for caption.
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Extended Data Fig. 3 | Comparison of the formulation of frequently reported culture media in spheroid research. Heat map showing the formulation 
of culture media types used in the empirical MISpheroID study, in addition with other media types frequently reported in spheroid research practices 
including L15, HamF12, HamF12K and McCoy’s5A. Ranked according to decreasing nutrient richness from left to right. Nutrients that are not included in 
a medium type appear as a grey space in its corresponding column. Left column indicates nutrient type. Numerical value of nutrients in each medium is 
indicated in each cell. Values are concentrations, expressed in mM, unless indicated *=µM, # =nM, $=mg/l.
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Extended Data Fig. 4 | Quantitative presentation of the impact of heterogeneity in culture medium on cell death in spheroids. Left, Z-score heatmaps 
and right, violin plots presenting the impact of six different media types on cell death in (a) 8 established cell lines and (b) 3 early passage, patient-derived 
sarcoma cultures. Biological replicates are indicated by a different symbol (N ≥ 3); each symbol is a technical replicate (n = 8). Y-axis represents 
log2-transformed data, all media types are normalized to DMEM HG. Horizontal bar indicates median. Statistical significance between the groups was 
determined with a one-way ANOVA and Tukey’s multiple comparison test. **p < 0.01, ***p < 0.001, ****p < 0.0001. Colors in violin plots present media 
type as in Fig. 3a; media types are ranked from higher nutrient (left) to lower nutrient (right) richness.
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Extended Data Fig. 5 | See next page for caption.
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Extended Data Fig. 5 | Image presentation of cell death, circularity and size in spheroids cultured in six different media types. Representative 
microscopy images show ethidium homodimer I stained (red if cell is dead) spheroids of all evaluated cell lines and patient-derived sarcoma cells (cell 
types indicated on the left) cultured in different media types (indicated on the top) (scale bars 200 µm). Each experiment was repeated independently at 
least 3 times with 8 technical replicates per experiment, with similar results. Media types are ranked from higher nutrient (left) to lower nutrient (right) 
richness. Intense staining in the spheroid center is indicative of necrotic core. Next to cell death, images give an indication of circularity and size.
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Extended Data Fig. 6 | Quantitative presentation of the impact of heterogeneity in culture medium on ATP content in spheroids. Left, Z-score 
heatmaps and right, violin plots presenting the impact of six different media types on ATP content in (a) 8 established cell lines and (b) 3 early passage, 
patient-derived sarcoma cultures. Biological replicates are indicated by a different symbol (N ≥ 3); each symbol is a technical replicate (n = 8). Y-axis 
represents log2-transformed data, all media types are normalized to DMEM HG. Horizontal bar indicates median. Statistical significance between the 
groups was determined with a one-way ANOVA and Tukey’s multiple comparison test. **p < 0.01, ***p < 0.001, ****p < 0.0001. Colors in violin plots 
present media type as in Fig. 3a; media types are ranked from higher nutrient (left) to lower nutrient (right) richness.
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Extended Data Fig. 7 | Quantitative presentation of the impact of heterogeneity in culture medium on ratio of glucose uptake to lactate secretion in 
spheroids. Left, Z-score heatmap and right, scatter diagram presenting the impact of six different media types on ratio of glucose (G) uptake to lactate 
(L) secretion (L/G ratio) in 5 established cell lines (N ≥ 2, n = 4). Indicative trendlines are presented in the scatter diagram with a dotted line (higher slope 
means a higher ratio of lactate secretion to glucose uptake (for example y = 2x; for the consumption of one glucose molecule 2 lactate molecules are 
produced)). Error bars indicate SD. Colors in scatter diagram present media type as in Fig. 3a; media types are ranked from higher nutrient (left) to lower 
nutrient (right) richness.
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Extended Data Fig. 8 | Quantitative presentation of the impact of heterogeneity in culture medium on size of spheroids. Left, Z-score heatmaps and 
right, violin plots presenting the impact of six different media types on spheroid size difference in (a) 8 established cell lines and (b) 3 early passage, 
patient-derived sarcoma cultures. Biological replicates are indicated by a different symbol (N ≥ 3); each symbol is a technical replicate (n = 8). Y-axis 
represents log2-transformed changes in size, all media types are normalized to DMEM HG. Horizontal bar indicates median. Statistical significance 
between the groups was determined with a one-way ANOVA and Tukey’s multiple comparison test. **p < 0.01, ***p < 0.001, ****p < 0.0001. Colors in 
violin plots present media type as in Fig. 3a; media types are ranked from higher nutrient (left) to lower nutrient (right) richness.
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Extended Data Fig. 9 | See next page for caption.
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Extended Data Fig. 9 | Response to radiotherapy of spheroids cultured in diverse media types. Bar plots (a and c); and Z-score heatmaps (b and d) 
respectively indicate the impact of a single (a and b) 20 Gy and (c and d) 10 Gy fraction on ATP content of spheroids of indicated cell lines cultured in 
different media types. Biological replicates are indicated by a different symbol (N = 2; except HEPG2 N = 1); each symbol is a technical replicate (n = 8). 
Statistical significance between the groups was determined with a one-way ANOVA and Tukey’s multiple comparison test. **p < 0.01, ***p < 0.001, 
****p < 0.0001. Horizontal bar indicates median, error bars indicate SD. Colors in bar plots present media type as in Fig. 3a; media types are ranked from 
higher nutrient (left) to lower nutrient (right) richness.
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Extended Data Fig. 10 | See next page for caption.
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Extended Data Fig. 10 | Evaluation of the metrics cell death, circularity and size in an interlaboratory study. (a) Correlation matrix of cell death ranking 
of HCT116 spheroids cultured in six different media types between different participating sites in the interlaboratory study (left) and between biological 
replicates in the study-initiating laboratory (right). In (b) and (c), Z-score heatmaps (left) and correlation matrices (right) present the impact of spheroid 
circularity (b) and size (c) of HCT116 spheroids cultured in six different media types evaluated across seven different sites in an interlaboratory setting. 
Media types in Z-score heatmaps are ranked from higher nutrient (left) to lower nutrient (right) richness. The median Spearman correlation across the 
entire dataset is respectively 0.56 for circularity and 0.57 for size. The larger spread in correlation coefficient of circularity across laboratories is due to 
subtle absolute differences with most probably limited biological significance.
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